PL3853218T3 - Modulatory somatostatyny i ich zastosowania - Google Patents
Modulatory somatostatyny i ich zastosowaniaInfo
- Publication number
- PL3853218T3 PL3853218T3 PL19863395.0T PL19863395T PL3853218T3 PL 3853218 T3 PL3853218 T3 PL 3853218T3 PL 19863395 T PL19863395 T PL 19863395T PL 3853218 T3 PL3853218 T3 PL 3853218T3
- Authority
- PL
- Poland
- Prior art keywords
- somatostatin modulators
- somatostatin
- modulators
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A61K9/4825—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Endocrinology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862732735P | 2018-09-18 | 2018-09-18 | |
| PCT/US2019/051514 WO2020061046A1 (en) | 2018-09-18 | 2019-09-17 | Somatostatin modulators and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3853218T3 true PL3853218T3 (pl) | 2025-06-02 |
Family
ID=69772634
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL19863395.0T PL3853218T3 (pl) | 2018-09-18 | 2019-09-17 | Modulatory somatostatyny i ich zastosowania |
Country Status (17)
| Country | Link |
|---|---|
| US (4) | US10696689B2 (pl) |
| EP (2) | EP3853218B1 (pl) |
| JP (1) | JP7431813B2 (pl) |
| AR (1) | AR116424A1 (pl) |
| DK (1) | DK3853218T3 (pl) |
| ES (1) | ES3022912T3 (pl) |
| FI (1) | FI3853218T3 (pl) |
| HR (1) | HRP20250425T1 (pl) |
| HU (1) | HUE071203T2 (pl) |
| LT (1) | LT3853218T (pl) |
| PL (1) | PL3853218T3 (pl) |
| PT (1) | PT3853218T (pl) |
| RS (1) | RS66720B1 (pl) |
| SI (1) | SI3853218T1 (pl) |
| SM (1) | SMT202500155T1 (pl) |
| TW (1) | TWI852944B (pl) |
| WO (1) | WO2020061046A1 (pl) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2017296392B2 (en) | 2016-07-14 | 2020-09-24 | Crinetics Pharmaceuticals, Inc. | Somatostatin modulators and uses thereof |
| KR20190121404A (ko) | 2017-03-16 | 2019-10-25 | 크리네틱스 파마슈티칼스, 인크. | 소마토스타틴 조절제 및 이의 용도 |
| US11608335B2 (en) | 2018-02-12 | 2023-03-21 | Crinetics Pharmaceuticals, Inc. | Somatostatin modulators and uses thereof |
| US10696689B2 (en) | 2018-09-18 | 2020-06-30 | Crinetics Pharmaceuticals, Inc. | Somatostatin modulators and uses thereof |
| US12617767B2 (en) | 2019-07-17 | 2026-05-05 | Crinetics Pharmaceuticals, Inc. | Crystalline forms of somatostatin modulators |
| TWI841768B (zh) | 2019-08-14 | 2024-05-11 | 美商克林提克斯醫藥股份有限公司 | 非肽生長抑制素(somatostatin)5型受體激動劑及其用途 |
| WO2022055880A1 (en) | 2020-09-09 | 2022-03-17 | Crinetics Pharmaceuticals, Inc. | Formulations of a somatostatin modulator |
| WO2022177974A1 (en) * | 2021-02-17 | 2022-08-25 | Crinetics Pharmaceuticals, Inc. | Crystalline forms of a somatostatin modulator |
| WO2024129614A1 (en) | 2022-12-13 | 2024-06-20 | Crinetics Pharmaceuticals, Inc. | Somatostatin subtype-2 receptor (sst2r) targeted therapeutics and uses thereof |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6127343A (en) | 1996-05-14 | 2000-10-03 | Novo Nordisk A/S | Somatostatin agonists and antagonists |
| US6025372A (en) | 1997-04-04 | 2000-02-15 | Merck & Co., Inc. | Somatostatin agonists |
| FR2802206B1 (fr) | 1999-12-14 | 2005-04-22 | Sod Conseils Rech Applic | Derives de 4-aminopiperidine et leur utilisation en tant que medicament |
| US20060281764A1 (en) | 2005-06-10 | 2006-12-14 | Gaul Michael D | Aminopyrimidines as kinase modulators |
| US20090258853A1 (en) | 2006-03-13 | 2009-10-15 | Brian Eastman | Somatostatin Agonists |
| KR101117931B1 (ko) | 2006-08-15 | 2012-04-12 | 에프. 호프만-라 로슈 아게 | 페닐, 피리딘 및 퀴놀린 유도체 |
| WO2009051705A1 (en) | 2007-10-18 | 2009-04-23 | Merck & Co., Inc. | Substituted 1,2,4-oxadiazoles and analogs thereof as cb2 receptor modulators, useful in the treatment of pain, respiratory and non-respiratory diseases |
| MX2011000177A (es) | 2008-06-25 | 2011-06-20 | Envivo Pharmaceuticals Inc | Compuestos fenilo di-substituido como inhibidores de fosfodiesterasa 10. |
| GB0818241D0 (en) | 2008-10-06 | 2008-11-12 | Cancer Res Technology | Compounds and their use |
| US20120157471A1 (en) | 2009-09-01 | 2012-06-21 | Pfizer Inc. | Benzimidazole derivatives |
| GB201008290D0 (en) | 2010-05-18 | 2010-06-30 | Syngenta Ltd | Chemical compounds |
| CA2799414A1 (en) | 2010-05-18 | 2011-11-24 | Merck Sharp & Dohme Corp. | Spiro isoxazoline compounds as sstr5 antagonists |
| JP6299591B2 (ja) | 2012-07-03 | 2018-03-28 | 小野薬品工業株式会社 | ソマトスタチン受容体作動活性を有する化合物およびその医薬用途 |
| BR112016007078A2 (pt) | 2013-09-30 | 2017-12-12 | Ono Pharmaceutical Co | composto tendo atividade agonística do receptor de somatostatina e uso farmacêutico do mesmo |
| ES2675504T3 (es) | 2013-10-02 | 2018-07-11 | Kuraray Co., Ltd. | Composición de resina, lámina de múltiples capas, material de envasado y recipiente |
| AU2017296392B2 (en) | 2016-07-14 | 2020-09-24 | Crinetics Pharmaceuticals, Inc. | Somatostatin modulators and uses thereof |
| JP6838387B2 (ja) * | 2016-12-21 | 2021-03-03 | トヨタ紡織株式会社 | 内装部品の取付構造 |
| MX2019009419A (es) | 2017-02-08 | 2019-10-02 | Ono Pharmaceutical Co | Compuesto que tiene actividad agonista del receptor de somatostatina y uso farmaceutico del mismo. |
| KR20190121404A (ko) | 2017-03-16 | 2019-10-25 | 크리네틱스 파마슈티칼스, 인크. | 소마토스타틴 조절제 및 이의 용도 |
| EP3658560A4 (en) | 2017-07-25 | 2021-01-06 | Crinetics Pharmaceuticals, Inc. | SOMATOSTAT IN MODULATORS AND USES THEREOF |
| US11608335B2 (en) | 2018-02-12 | 2023-03-21 | Crinetics Pharmaceuticals, Inc. | Somatostatin modulators and uses thereof |
| US10696689B2 (en) | 2018-09-18 | 2020-06-30 | Crinetics Pharmaceuticals, Inc. | Somatostatin modulators and uses thereof |
| TWI841768B (zh) | 2019-08-14 | 2024-05-11 | 美商克林提克斯醫藥股份有限公司 | 非肽生長抑制素(somatostatin)5型受體激動劑及其用途 |
-
2019
- 2019-09-17 US US16/572,921 patent/US10696689B2/en active Active
- 2019-09-17 EP EP19863395.0A patent/EP3853218B1/en active Active
- 2019-09-17 EP EP25151398.2A patent/EP4548974A3/en active Pending
- 2019-09-17 DK DK19863395.0T patent/DK3853218T3/da active
- 2019-09-17 RS RS20250348A patent/RS66720B1/sr unknown
- 2019-09-17 AR ARP190102640A patent/AR116424A1/es unknown
- 2019-09-17 ES ES19863395T patent/ES3022912T3/es active Active
- 2019-09-17 FI FIEP19863395.0T patent/FI3853218T3/fi active
- 2019-09-17 JP JP2021514532A patent/JP7431813B2/ja active Active
- 2019-09-17 HR HRP20250425TT patent/HRP20250425T1/hr unknown
- 2019-09-17 PT PT198633950T patent/PT3853218T/pt unknown
- 2019-09-17 WO PCT/US2019/051514 patent/WO2020061046A1/en not_active Ceased
- 2019-09-17 SI SI201930927T patent/SI3853218T1/sl unknown
- 2019-09-17 PL PL19863395.0T patent/PL3853218T3/pl unknown
- 2019-09-17 TW TW108133468A patent/TWI852944B/zh active
- 2019-09-17 SM SM20250155T patent/SMT202500155T1/it unknown
- 2019-09-17 HU HUE19863395A patent/HUE071203T2/hu unknown
- 2019-09-17 LT LTEPPCT/US2019/051514T patent/LT3853218T/lt unknown
-
2020
- 2020-05-19 US US16/877,947 patent/US11186590B2/en active Active
-
2021
- 2021-10-26 US US17/511,326 patent/US20220048924A1/en not_active Abandoned
-
2022
- 2022-04-06 US US17/714,825 patent/US11834462B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US11186590B2 (en) | 2021-11-30 |
| RS66720B1 (sr) | 2025-05-30 |
| EP3853218B1 (en) | 2025-02-19 |
| HUE071203T2 (hu) | 2025-08-28 |
| TW202024095A (zh) | 2020-07-01 |
| JP7431813B2 (ja) | 2024-02-15 |
| US11834462B2 (en) | 2023-12-05 |
| LT3853218T (lt) | 2025-05-12 |
| AR116424A1 (es) | 2021-05-05 |
| HRP20250425T1 (hr) | 2025-06-20 |
| TWI852944B (zh) | 2024-08-21 |
| US20200283453A1 (en) | 2020-09-10 |
| US20200087318A1 (en) | 2020-03-19 |
| SI3853218T1 (sl) | 2025-06-30 |
| PT3853218T (pt) | 2025-04-02 |
| WO2020061046A1 (en) | 2020-03-26 |
| FI3853218T3 (fi) | 2025-04-15 |
| JP2022501342A (ja) | 2022-01-06 |
| DK3853218T3 (da) | 2025-04-22 |
| EP4548974A3 (en) | 2025-08-13 |
| ES3022912T3 (en) | 2025-05-29 |
| SMT202500155T1 (it) | 2025-05-12 |
| EP4548974A2 (en) | 2025-05-07 |
| US20230022513A1 (en) | 2023-01-26 |
| EP3853218A4 (en) | 2022-02-16 |
| EP3853218A1 (en) | 2021-07-28 |
| US10696689B2 (en) | 2020-06-30 |
| US20220048924A1 (en) | 2022-02-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL269241A (en) | Somatostatin modulators and their uses | |
| ZA201900317B (en) | Somatostatin modulators and uses thereof | |
| ZA202002184B (en) | Adenovirus and uses thereof | |
| ZA202002191B (en) | Adenovirus and uses thereof | |
| SMT202500155T1 (it) | Modulatori della somatostatina e loro usi | |
| IL294052B2 (en) | Fluoroalkyl oxadiazoles and their uses | |
| IL291345A (en) | il-17a modulators and their uses | |
| EP3317277A4 (en) | Somatostatin modulators and uses thereof | |
| IL277502A (en) | Compounds and uses for them | |
| ZA202105847B (en) | Mtroc modulators and uses thereof | |
| IL280808A (en) | OX40-binding polypeptides and their uses | |
| EP3317278A4 (en) | Somatostatin modulators and uses thereof | |
| IL274220A (en) | Adenovirus and its uses | |
| IL277548A (en) | Modulators of caplain and their medicinal uses | |
| ZA201905513B (en) | Rorgamma modulators and uses thereof | |
| SG11202006669RA (en) | Peptides and uses thereof | |
| IL287503A (en) | Thio-semicarbazide compounds and their use | |
| IL279483A (en) | Cyanotriazole compounds and their uses | |
| ZA201905511B (en) | Rorgamma modulators and uses thereof | |
| IL273671A (en) | Cornoline variants and their use | |
| IL280369A (en) | Myokines and their uses | |
| HUE068738T2 (hu) | Új szelektív ACKR3-modulátorok és alkalmazásaik | |
| HK40016442A (en) | Rorgamma modulators and uses thereof | |
| HK40016459A (en) | Rorgamma modulators and uses thereof | |
| HK40016461A (en) | Rorgamma modulators and uses thereof |